Cargando…

Privacy-preserving genomic testing in the clinic: a model using HIV treatment

PURPOSE: The implementation of genomic-based medicine is hindered by unresolved questions regarding data privacy and delivery of interpreted results to health-care practitioners. We used DNA-based prediction of HIV-related outcomes as a model to explore critical issues in clinical genomics. Genet Me...

Descripción completa

Detalles Bibliográficos
Autores principales:	McLaren, Paul J., Raisaro, Jean Louis, Aouri, Manel, Rotger, Margalida, Ayday, Erman, Bartha, István, Delgado, Maria B., Vallet, Yannick, Günthard, Huldrych F., Cavassini, Matthias, Furrer, Hansjakob, Doco-Lecompte, Thanh, Marzolini, Catia, Schmid, Patrick, Di Benedetto, Caroline, Decosterd, Laurent A., Fellay, Jacques, Hubaux, Jean-Pierre, Telenti, Amalio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985613/ https://www.ncbi.nlm.nih.gov/pubmed/26765343 http://dx.doi.org/10.1038/gim.2015.167

Ejemplares similares

On genomics, kin, and privacy
por: Telenti, Amalio, et al.
Publicado: (2014)

Determinants of Sustained Viral Suppression in HIV-Infected Patients with Self-Reported Poor Adherence to Antiretroviral Therapy
por: Glass, Tracy R., et al.
Publicado: (2012)

Estimating the Net Contribution of Interleukin-28B Variation to Spontaneous Hepatitis C Virus Clearance
por: di Iulio, Julia, et al.
Publicado: (2011)

GuavaH: a compendium of host genomic data in HIV biology and disease
por: Bartha, István, et al.
Publicado: (2014)

Genome-Wide mRNA Expression Correlates of Viral Control in CD4+ T-Cells from HIV-1-Infected Individuals
por: Rotger, Margalida, et al.
Publicado: (2010)

Identification of Siglec-1 null individuals infected with HIV-1
por: Martinez-Picado, Javier, et al.
Publicado: (2016)

Estimating the Respective Contributions of Human and Viral Genetic Variation to HIV Control
por: Bartha, István, et al.
Publicado: (2017)

A privacy-preserving solution for compressed storage and selective retrieval of genomic data
por: Huang, Zhicong, et al.
Publicado: (2016)

Disentangling Human Tolerance and Resistance Against HIV
por: Regoes, Roland R., et al.
Publicado: (2014)

Analysis of Stop-Gain and Frameshift Variants in Human Innate Immunity Genes
por: Rausell, Antonio, et al.
Publicado: (2014)

The Characteristics of Heterozygous Protein Truncating Variants in the Human Genome
por: Bartha, István, et al.
Publicado: (2015)

Revolutionizing Medical Data Sharing Using Advanced Privacy-Enhancing Technologies: Technical, Legal, and Ethical Synthesis
por: Scheibner, James, et al.
Publicado: (2021)

Adverse events of raltegravir and dolutegravir
por: Elzi, Luigia, et al.
Publicado: (2017)

Truly privacy-preserving federated analytics for precision medicine with multiparty homomorphic encryption
por: Froelicher, David, et al.
Publicado: (2021)

Mapping of positive selection sites in the HIV-1 genome in the context of RNA and protein structural constraints
por: Snoeck, Joke, et al.
Publicado: (2011)

Author Correction: Truly privacy-preserving federated analytics for precision medicine with multiparty homomorphic encryption
por: Froelicher, David, et al.
Publicado: (2021)

Brief Report: Switching From TDF to TAF in HIV/HBV-Coinfected Individuals With Renal Dysfunction—A Prospective Cohort Study
por: Surial, Bernard, et al.
Publicado: (2020)

Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland
por: Thoueille, Paul, et al.
Publicado: (2022)

IL-4 polymorphism influences susceptibility to Pneumocystis jirovecii pneumonia in HIV-positive patients
por: Wójtowicz, Agnieszka, et al.
Publicado: (2019)

24 Hours in the Life of HIV-1 in a T Cell Line
por: Mohammadi, Pejman, et al.
Publicado: (2013)

Correction: 24 Hours in the Life of HIV-1 in a T Cell Line
por: Mohammadi, Pejman, et al.
Publicado: (2015)

HIV and innate immunity – a genomics perspective
por: Rausell, Antonio, et al.
Publicado: (2013)

Increases in Condomless Sex in the Swiss HIV Cohort Study
por: Kouyos, Roger D., et al.
Publicado: (2015)

CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART
por: Sauter, Rafael, et al.
Publicado: (2016)

Development and validation of a multiplex UHPLC‐MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HIV
por: Courlet, Perrine, et al.
Publicado: (2020)

Dynamics of HIV Latency and Reactivation in a Primary CD4+ T Cell Model
por: Mohammadi, Pejman, et al.
Publicado: (2014)

Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study
por: Castillo-Mancilla, Jose R, et al.
Publicado: (2021)

Development and Validation of Decision Rules to Guide Frequency of Monitoring CD4 Cell Count in HIV-1 Infection before Starting Antiretroviral Therapy
por: Buclin, Thierry, et al.
Publicado: (2011)

Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population
por: Gueler, Aysel, et al.
Publicado: (2017)

Data protection and ethics requirements for multisite research with health data: a comparative examination of legislative governance frameworks and the role of data protection technologies
por: Scheibner, James, et al.
Publicado: (2020)

Phylogenetic Approach Reveals That Virus Genotype Largely Determines HIV Set-Point Viral Load
por: Alizon, Samuel, et al.
Publicado: (2010)

Retroviruses As Myeloid Cell Riders: What Natural Human Siglec-1 “Knockouts” Tell Us About Pathogenesis
por: Martinez-Picado, Javier, et al.
Publicado: (2017)

A Novel Acute Retroviral Syndrome Severity Score Predicts the Key Surrogate Markers for HIV-1 Disease Progression
por: Braun, Dominique L., et al.
Publicado: (2014)

Correction: Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens
por: Scherrer, Alexandra U., et al.
Publicado: (2013)

Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens
por: Scherrer, Alexandra U., et al.
Publicado: (2012)

Factors Associated With Liver Steatosis in People With Human Immunodeficiency Virus on Contemporary Antiretroviral Therapy
por: Riebensahm, Carlotta, et al.
Publicado: (2022)

Mapping of positive selection sites in the HIV genome in the context of RNA and protein structural constraints
por: Snoeck, Joke, et al.
Publicado: (2011)

Adherence as a Predictor of the Development of Class-Specific Resistance Mutations: The Swiss HIV Cohort Study
por: von Wyl, Viktor, et al.
Publicado: (2013)

Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor–Based Antiretroviral Treatment
por: Pyngottu, Ashima, et al.
Publicado: (2020)

A39 Human exome sequencing to evaluate the impact of rare coding variation on HIV-1 control
por: McLaren, P.J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u23vol4r07v76qg2vpea9e8ob2